Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2023 07:33 ET | Source: Novartis Pharma AG

Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation

Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use in all indications of reference medicine Humira®*HCF formulation adalimumab offers...
February 06, 2023 01:15 ET | Source: Novartis Pharma AG

Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA

Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including osteoporosis in postmenopausal women1,2 Sandoz...
December 18, 2019 04:00 ET | Source: IncludeHealth

IncludeHealth Secures Licensing Agreement from Cincinnati Children’s Hospital Medical Center

Cincinnati, OHIO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- IncludeHealth, an internationally recognized provider of inclusive digital health and performance technologies, and Cincinnati Children’s Hospital...
July 03, 2019 09:00 ET | Source: eWellness Healthcare Corp

eWellness Announces Renewed Focus on the $4 Billion North American Musculoskeletal Treatment Market

Culver City, CA, July 03, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth...